Surrozen, Inc. (SRZN)
SRZN moved a median of 0.00% 30 minutes after news, and -0.74% by the close. How SRZN actually reacts to news — the realized, point-in-time move the market made, measured across 262 labeled events over the last three years with zero look-ahead.
SRZN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 183 |
| 30-min | 0.00% | 38% | 216 |
| 60-min | 0.00% | 44% | 234 |
| to close | -0.74% | 47% | 259 |
| Middle 50% of SRZN reactions | -1.92% to +1.58% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 262 |
Half of all Surrozen, Inc. news events land between -1.92% and +1.58% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How SRZN reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 13 | 0.00% | 46% | -0.49% |
| Rating reiterations | 15 | -1.02% | 47% | -0.83% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how SRZN ranks against every other measured name →
That’s how SRZN usually reacts — get an email when it moves on news →Email me when SRZN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SRZN's baseline. Nothing else.
Recent SRZN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Surrozen, Inc./DE For: Oct 20 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million | Press release | GlobeNewswire | — | — | |
| Form 8-K Surrozen, Inc./DE For: Oct 02 | SEC filing · Form 8-K | SEC EDGAR | -1.64% | -4.09% | |
| Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema | Press release | GlobeNewswire | -1.64% | -4.09% | |
| Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema | Press release | GlobeNewswire | -1.91% | -8.37% | |
| Surrozen to Present at Upcoming Healthcare Investor Conferences | Press release | GlobeNewswire | -1.59% | -1.66% | |
| Form 10-Q Surrozen, Inc./DE For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -8.21% | +3.14% | |
| Form 8-K Surrozen, Inc./DE For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -8.21% | +3.14% | |
| Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | GlobeNewswire | -8.21% | +3.14% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | -1.63% | -4.86% | |
| Form 8-K Surrozen, Inc./DE For: May 13 | SEC filing · Form 8-K | SEC EDGAR | — | -2.29% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | +0.00% | -1.86% | |
| Form 10-Q Surrozen, Inc./DE For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.17% | -12.14% | |
| Form 8-K Surrozen, Inc./DE For: May 06 | SEC filing · Form 8-K | SEC EDGAR | -1.17% | -12.14% | |
| Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | GlobeNewswire | -1.17% | -12.14% | |
| Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -1.01% | +3.27% | |
| Form ARS Surrozen, Inc./DE For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.69% | +0.11% | |
| Form DEF 14A Surrozen, Inc./DE For: Apr 01 | SEC filing · Form DEF | SEC EDGAR | +1.69% | +0.11% | |
| Form DEFA14A Surrozen, Inc./DE | SEC filing · Form DEFA14A | SEC EDGAR | +1.69% | +0.11% | |
| Form EFFECT Surrozen, Inc./DE | SEC filing · Form EFFECT | SEC EDGAR | -1.65% | +4.41% | |
| Form 10-K Surrozen, Inc./DE For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -0.83% | |
| Form 8-K Surrozen, Inc./DE For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.83% | |
| Form S-3 Surrozen, Inc./DE | SEC filing · Form S-3 | SEC EDGAR | +0.00% | -0.83% | |
| Form S-8 Surrozen, Inc./DE | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -0.83% | |
| Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Press release | GlobeNewswire | +0.00% | -0.83% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | +0.00% | — | |
| Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +1.14% | +2.94% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | +0.00% | +6.94% | |
| Form 8-K Surrozen, Inc./DE For: Jan 26 | SEC filing · Form 8-K | SEC EDGAR | — | +3.46% | |
| Surrozen to Present at Upcoming Healthcare Investor Conferences | Press release | GlobeNewswire | +0.94% | +3.36% | |
| Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +0.00% | — | |
| Form 10-Q Surrozen, Inc./DE For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -1.67% | |
| Form 8-K Surrozen, Inc./DE For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.67% | |
| Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | GlobeNewswire | +0.00% | -1.67% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | — | +1.87% | |
| Form 8-K Surrozen, Inc./DE For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | -0.15% | +2.76% | |
| Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | — | -2.40% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | — | -0.56% | |
| Form 8-K Surrozen, Inc./DE For: Aug 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.41% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | — | +7.93% | |
| Form 10-Q Surrozen, Inc./DE For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +3.58% | |
| Form 8-K Surrozen, Inc./DE For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.58% | |
| Form S-8 Surrozen, Inc./DE | SEC filing · Form S-8 | SEC EDGAR | +0.00% | +3.58% | |
| Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | GlobeNewswire | +0.00% | +3.58% | |
| Surrozen to Present at Upcoming Healthcare Investor Conference | Press release | GlobeNewswire | +1.40% | -9.79% | |
| Form EFFECT Surrozen, Inc./DE | SEC filing · Form EFFECT | SEC EDGAR | — | -0.78% | |
| Form S-3 Surrozen, Inc./DE | SEC filing · Form S-3 | SEC EDGAR | — | -7.70% | |
| Form 8-K Surrozen, Inc./DE For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +1.45% | +14.33% | |
| Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway | Press release | GlobeNewswire | -2.50% | -9.72% | |
| Form 10-Q Surrozen, Inc./DE For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | -4.76% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SRZN section they belong to.
Where else SRZN is measured.
SRZN earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Surrozen, Inc.'s median reaction calculated?
Every labeled SRZN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 262 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of SRZN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SRZN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.